Part 2 – High Value Therapeutics
7:00-8:00 pm IST/ 9:30-10:30 am ET
Zoom link for the talk
Stream the talk on YouTube
The science and practice of Covid-19 clinical care continues to evolve as new discoveries change our treatment options, management of complications and influence vaccination strategies. The Mittal Institute, with the support of the Harvard T.H. Chan School of Public Health, the Lancet Citizens’ Commission on Reimagining India’s Health System, and the Swasth Community Science Alliance, is organizing a series of panel discussions by leading scientists and frontline clinicians on the latest evidence-based updates for COVID-19 care. Our goal through these talks is to assist with the management of COVID-19 and improvement of health outcomes in South Asia.
This session will focus on high value therapeutics for COVID-19 patients, including the latest evidence-based reasoning for their use and impact.
Amita Sudhir, Associate Professor of Emergency Medicine, University of Virginia School of Medicine
- Priya Nori, Associate Professor of Medicine & Orthopedic Surgery, Albert Einstein College of Medicine
- Rajesh T. Gandhi, Professor of Medicine, Harvard Medical School
- Shitij Arora, Associate Professor in Medicine, Albert Einstein College of Medicine